Teodora Wi

Teodora Wi

researcher Switzerland

Teodora Wi is a representative of the World Health Organization, recognized for her research in infectious diseases and public health. Along with Magnus Unemo, she co-authored a commentary on the study of gepotidacin, addressing concerns about the development of resistance in gonorrhea and the necessity for new treatment options.

Global Media Ratings
Dominance
0.01%
Persistence
0 wks
Reach
148,033
Power
9,392$
Sentiment
5.00
Countries Mentioned
Country Mentions Sentiment Dominance + Persistence x Population = Reach x GDP (millions) = Power
United States 1 5.00 0.04% +0% 331,002,651 148,033 $21,000,000 9,392$
Totals 1 331,002,651 148,033 $21,000,000 9,392$
Interactive World Map

Each country's color is based on "Mentions" from the table above.

Recent Mentions

United States United States: Teodora Wi of the World Health Organization highlighted the importance of continued development of additional gonorrhea treatments. 5

CNN: FDA approves first new antibiotics to treat gonorrhea in decades, with hope to combat drug resistance

Canada Canada: Teodora Wi is a researcher who co-authored a Lancet editorial discussing the challenges of retaining gonorrhea as a treatable infection. 6

The Globe and Mail: Promising new antibiotic is one of first viable gonorrhea drug candidates since 1990s

United States United States: Teodora Wi is associated with the World Health Organization and co-authored a comment paper on gepotidacin resistance. 5

CNN: Gepotidacin: New antibiotic is effective against gonorrhea, could be first new treatment since 1990s, study says